[Asia Economy Reporter Hwang Yoon-joo]
▲Hans Biomed = CB conversion price adjusted from 10,167 KRW to 10,109 KRW
▲Cass = CB conversion price adjusted from 2,351 KRW to 2,080 KRW
▲SPG = Corporate presentation (IR) to be held on the 22nd... Explanation of management status
▲DNA Link = Confirmation of application for appointment of examiner
▲EV Suseong = Decision on third-party allotment paid-in capital increase worth 16 billion KRW
Hot Picks Today
"Pay for the Postpartum Care Center with My Car...
- “Everyone Said You’d Make Money” ? Chinese Investors Rush In and Lose Princip...
- Share of Outside Directors from Business Sector Surpasses 20% for the First Time...
- "You Should Throw This Food Out of Your Fridge Immediately"... Eating This 'Zero...
- Once a Leading 'Outdoor Legend'...Is Nepa Headed Down the Same Path as Homeplus?...
▲Zenen Bio = Reapplication for single-center, open-label Phase 1 clinical trial plan (IND) to evaluate the safety and efficacy of pig islet transplantation in diabetic patients
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
